|
OMIM |
Link |
Information gain |
01 |
|
schistosoma mansoni infection, susceptibility/resistance to
|
[NCBI]
|
0.0043503
|
|
|
hepatic fibrosis, severe, susceptibility to, due to schistosoma mansoni infection
|
[NCBI]
|
0.00243653
|
|
|
SLE
|
[NCBI]
|
6.86764e-05
|
|
|
IL31RA
|
[NCBI]
|
6.70987e-05
|
|
|
VNN1
|
[NCBI]
|
6.70987e-05
|
|
|
IL21R
|
[NCBI]
|
6.19002e-05
|
|
|
IL13RA2
|
[NCBI]
|
5.85252e-05
|
|
|
VIP
|
[NCBI]
|
4.44627e-05
|
|
|
IFNGR1
|
[NCBI]
|
4.31161e-05
|
|
|
IL5
|
[NCBI]
|
4.25339e-05
|
|
|
CD40LG
|
[NCBI]
|
3.88137e-05
|
|
|
NGFB
|
[NCBI]
|
3.87663e-05
|
|
|
TRPV1
|
[NCBI]
|
3.80688e-05
|
|
|
CCL22
|
[NCBI]
|
3.13465e-05
|
|
|
CCL2
|
[NCBI]
|
3.13465e-05
|
|
|
RNASE3
|
[NCBI]
|
2.40735e-05
|
|
|
TNFSF6
|
[NCBI]
|
2.30085e-05
|
|
|
PLG
|
[NCBI]
|
2.19125e-05
|
|
|
GJA1
|
[NCBI]
|
2.05105e-05
|
|
|
CYP1A1
|
[NCBI]
|
1.88647e-05
|
|
|
PCNA
|
[NCBI]
|
1.86667e-05
|
|
|
LCAT
|
[NCBI]
|
1.74381e-05
|
|
|
IL2
|
[NCBI]
|
1.5329e-05
|
|
|
PF4
|
[NCBI]
|
1.36725e-05
|
|
|
ALB
|
[NCBI]
|
1.31325e-05
|
|
|
SOD2
|
[NCBI]
|
1.30616e-05
|
|
|
RA
|
[NCBI]
|
1.02637e-05
|
|
|
MPO
|
[NCBI]
|
8.73748e-06
|
|
|
VDR
|
[NCBI]
|
6.92297e-06
|
|
|
G6PD
|
[NCBI]
|
5.1572e-06
|
|
|
CAT
|
[NCBI]
|
4.20777e-06
|
|
|
ACHE
|
[NCBI]
|
3.48023e-06
|
|
|
TNF
|
[NCBI]
|
2.1411e-06
|
|
|
APOE
|
[NCBI]
|
1.27315e-06
|
|
|
VEGF
|
[NCBI]
|
1.79554e-07
|
|